Naproxen Sodium Marel B.V.

Naproxen Sodium, the active ingredient in Naproxen Sodium Marel B.V., is a nonsteroidal anti-inflammatory drug presented as an oral tablet for oral use. It provides analgesic, anti‑inflammatory and antipyretic effects for the relief of pain, swelling and fever in adult patients.

GNH USA supplies Naproxen Sodium Marel B.V. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution for this NSAID. Customers benefit from consistent product availability and comprehensive regulatory support.

Naproxen Sodium belongs to the NSAID class and is used to manage conditions involving pain, inflammation and fever.

- Pain: Provides relief of mild to moderate acute pain such as headache, dental pain, or musculoskeletal discomfort. - Inflammation: Decreases swelling and inflammation in conditions like sprains, strains, and soft‑tissue injuries. - Fever: Lowers elevated body temperature associated with febrile illnesses. - Arthritis: Alleviates joint pain and stiffness in osteoarthritis and rheumatoid arthritis.

Naproxen Sodium may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Gastrointestinal discomfort: dyspepsia, abdominal pain, or nausea. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Mild skin rash or itching.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding, which can be life‑threatening. - Renal impairment, including acute kidney injury. - Severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Cardiovascular events, including increased risk of myocardial infarction or stroke.

When using Naproxen Sodium, several precautions should be observed to minimize risk.

- Assess renal function: evaluate baseline kidney status before initiating therapy. - Monitor gastrointestinal health: consider ulcer prophylaxis in high‑risk patients. - Check cardiovascular risk: avoid in patients with uncontrolled hypertension or recent myocardial infarction. - Avoid use in late pregnancy: contraindicated during the third trimester. - Store at ambient temperature: keep below 25 °C in the original pack, protect from moisture.

Naproxen Sodium can interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Selective COX‑2 inhibitors: additive cardiovascular risk. - Lithium: elevated lithium serum concentrations. - Methotrexate: reduced clearance leading to toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or diuretics: may impair renal function. - Corticosteroids: heightened gastrointestinal ulcer risk. - SSRIs or SNRIs: increased potential for bleeding.